ASSURE Wearable ECG vs Eko Low Ejection Fraction Tool (ELEFT)
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 70/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
VS
AI Verdict
Tool A, the ASSURE Wearable ECG, is designed for continuous heart rate monitoring and data collection in at-risk cardiac patients, focusing on ongoing management and trend analysis. In contrast, Tool B, the Eko Low Ejection Fraction Tool (ELEFT), provides AI-powered screening for early detection of low ejection fraction during routine physical exams. While both are FDA-cleared cardiology AI solutions, Tool A is geared towards continuous remote patient monitoring, whereas Tool B serves as a point-of-care diagnostic aid for heart failure risk.
Choose ASSURE Wearable ECG if…
Choose the ASSURE Wearable ECG if you require continuous, long-term heart rate monitoring and detailed ECG data collection for at-risk cardiac patients. This tool is ideal for remote patient management, allowing clinicians to review physiologic trend data and receive alert-based notifications for ongoing, comprehensive oversight of patient cardiac health.
View ASSURE Wearable ECG →Choose Eko Low Ejection Fraction Tool (ELEFT) if…
Choose the Eko Low Ejection Fraction Tool (ELEFT) if you need a quick, non-invasive screening tool to aid in the early detection of low ejection fraction during routine physical exams. This AI-powered solution is best suited for clinicians in primary care or cardiology seeking to identify potential heart failure risk efficiently at the point of care.
View Eko Low Ejection Fraction Tool (ELEFT) →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | ASSURE Wearable ECG | Eko Low Ejection Fraction Tool (ELEFT) |
|---|---|---|
| Deployment | The ASSURE system is intended for use by a patient during their normal daily activities primarily in the home or community setting, but also hospitals, medical clinics, healthcare facilities and transport. | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | ASSURE Wearable ECG | Eko Low Ejection Fraction Tool (ELEFT) |
|---|---|---|
| Name | ASSURE Wearable ECG | Eko Low Ejection Fraction Tool (ELEFT) |
| Company | Kestra Medical Technologies | Eko Health |
| Primary Function | Non-therapeutic device for continuous heart rate monitoring and data collection. | FDA-cleared AI algorithm to aid clinicians in early detection of low ejection fraction. |
| Core Technology / Device Type | Wearable ECG device (SensorFit Garment) with embedded ECG sensors. | AI algorithm that integrates with Eko digital stethoscopes. |
| Key Detection/Monitoring | Continuous heart rate monitoring, automatic episode storage, physiologic trend data. | AI-powered low ejection fraction detection, analyzes ECG and heart sound recordings. |
| Specialties | Cardiology | Cardiology, Family Medicine, Internal Medicine |
Videos
Demos, reviews, and walkthroughs featuring ASSURE Wearable ECG and Eko Low Ejection Fraction Tool (ELEFT).
Loading videos…
Videos need JavaScript to load. Search YouTube directly →
Frequently Asked Questions
The ASSURE Wearable ECG is designed for continuous heart rate monitoring and data collection in at-risk cardiac patients, providing ongoing insights into cardiac activity. In contrast, the Eko Low Ejection Fraction Tool (ELEFT) is an AI algorithm used during routine physical exams to aid in the early detection of low ejection fraction, a key indicator of heart failure.
The ASSURE Wearable ECG collects continuous heart rate and ECG data via its wearable device and SensorFit Garment. The Eko Low Ejection Fraction Tool analyzes ECG and heart sound recordings captured by an integrated Eko digital stethoscope.
The ASSURE Wearable ECG is primarily suited for Cardiology, focusing on continuous monitoring of at-risk cardiac patients. Eko's ELEFT is applicable across Cardiology, Family Medicine, and Internal Medicine, aiding in early heart failure risk detection during routine exams.
The ASSURE Wearable ECG focuses on continuous heart rate monitoring, automatic episode storage, and physiologic trend data for general cardiac surveillance. Eko's ELEFT specifically targets the early detection of low ejection fraction, which is a critical indicator of heart failure.
The ASSURE Wearable ECG requires its proprietary wearable device, SensorFit Garment, and access to the Kestra CareStation remote patient data platform. Eko's ELEFT integrates with existing FDA-cleared Eko digital stethoscopes and operates as a cloud-based software within the SENSORAu2122 Cardiac Early Detection Platform.
The ASSURE Wearable ECG provides continuous monitoring with automatic episode storage and alert-based notifications, offering ongoing data and trends. The Eko Low Ejection Fraction Tool delivers its low ejection fraction detection results rapidly, in approximately 15 seconds, during a physical exam.
More Comparisons
More matchups featuring ASSURE Wearable ECG or Eko Low Ejection Fraction Tool (ELEFT)
Backers
Who funded each tool's parent company.